Call for Papers

Dear Colleagues,

We are delighted to announce that Scilight Publishers has just launched a new academic journal, Journal of Cardiovascular and Metabolic Disease Epidemiology (JCMDE). From now, we are cordially invite you to take advantage of this portfolio to showcase high-quality research in the fields of cardiovascular and metabolic diseases, including obesity, hyperlipidemias, fatty liver disease, and diabetes. 

Aims & Scope

 The Journal of Cardiovascular and Metabolic Disease Epidemiology is a gold open access, peer-reviewed journal that aims to publish high-quality research in the fields of cardiovascular and metabolic diseases, including obesity, hyperlipidemias, fatty liver disease, and diabetes. Its focus is on the epidemiology, prevention, diagnosis, and management of these conditions, with the goal of advancing knowledge and improving public health outcomes. The journal welcomes original research articles, systematic reviews and meta-analyses, of epidemiologic studies or clinical trials, that substantially contribute to the understanding of risk factors, disease mechanisms, and interventions related to cardiovascular and metabolic diseases. Methodological articles that contribute to the development of novel tools, or methods for better understanding cardiovascular and metabolic disease paths, are also welcome. Narrative reviews, and commentary articles on recently published research, are considered after invitation. As a gold open access journal, all articles are freely accessible to the public, ensuring wide dissemination of research findings. It is published quarterly online by Scilight Press.

The primary goal of the Journal of Cardiovascular and Metabolic Disease Epidemiology is to advance understanding of the determinants and trends of all aspects of cardiovascular and metabolic diseases across diverse populations worldwide. The journal emphasizes research that investigates the biological and physiological mechanisms underlying these diseases, including metabolic pathways, lipid, inflammation, and cellular processes. It also prioritizes studies that explore the genetic, environmental, socio-demographic, nutritional, behavioral, and lifestyle factors contributing to disease development. Additionally, the journal focuses on public health strategies aimed at preventing cardiovascular and metabolic diseases on a population level, including interventions, policy recommendations, and health promotion efforts. A key goal is to address disparities in disease outcomes across different populations by examining social determinants of health, access to care, and health equity. Research on the global burden of cardiovascular and metabolic diseases, particularly studies that highlight disease patterns in low- and middle-income countries and global health initiatives, is also strongly encouraged.

Indexing & Archiving

Digital Preservation
National Library of Australia
Content Aggregators
Google Scholar
Scilit

Free Publication Offer

We are excited to announce that for a limited time, we are offering free publication for all accepted manuscripts. This means that authors will not be charged any article processing charges (APC) for papers published during this period. We believe that removing financial barriers to publication will encourage a wider range of high-quality research to be shared with the global community.

Why JCMDE?

Journal of Cardiovascular and Metabolic Disease Epidemiology is committed to rapid publication and a rigorous peer-review process to ensure the quality of the research we publish. By submitting your work to Journal of Cardiovascular and Metabolic Disease Epidemiology, you are joining a community of scholars and researchers dedicated to advancing the science of cardiovascular and metabolic diseases.

How to Submit

Please prepare your manuscript according to our submission guidelines and submit it through our online submission system. For any questions or assistance, do not hesitate to contact our editorial office.

Deadline

While Journal of Cardiovascular and Metabolic Disease Epidemiology operates on a continuous publication model, we encourage timely submissions for priority consideration.

We look forward to receiving your innovative contributions and to working together in advancing the field of cardiovascular and metabolic diseases.

Editor-in-Chief
Prof. Demosthenes Panagiotakos